Impact of SARS-CoV-2 pandemic on pancreatic cancer: diagnosis and short-term survival
Author(s) -
Javier TejedorTejada,
César Gómez-Díez,
Samuel Robles Gaitero,
Ana Villar Caamaño,
Benito Hermida,
José Manuel Olmos,
Aránzazu Álvarez Álvarez,
Rafael Tojo González
Publication year - 2022
Publication title -
revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2022.8772/2022
Subject(s) - medicine , pandemic , covid-19 , pancreatic cancer , stage (stratigraphy) , demographics , gastroenterology , cancer , survival analysis , adenocarcinoma , pediatrics , disease , infectious disease (medical specialty) , paleontology , demography , sociology , biology
The COVID-19 pandemic has delayed medical consultation, possibly leading to the diagnosis of gastrointestinal cancer. The aim of the study was to analyze the impact of SARS-Cov-2 pandemic on new diagnosis and short-term survival of patients with pancreatic cancer (PC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom